Children, Adults With Tuberculosis Have Same Risk of Resistance in Most Countries - Infectious Disease Advisor

-

In most settings, children and adults are at equal risk of developing multidrug resistant (MDR) or rifampicin resistant (RR) tuberculosis (TB), but there are important gaps in data that limit this understanding, according to a study that was recently published in the European Respiratory Journal.

World Health Organization (WHO) estimated 484,000 cases of 10 million incident TB cases were MDR (resistance to both rifampicin and isoniazid) or RR in 2018. MDR/RR-TB have significantly higher rates of treatment failure and mortality compared to TB that are not MDR or RR. As a result, treatment of MDR/RR-TB involves expensive, toxic drugs over extended periods of time. Previous evidence suggests that children are not more or less likely to develop or have MDR/RR-TB when compared to adults. New available data in high MDR/RR-TB countries warrants a further country-specific look.

WHO reports annually on aggregated drug resistance surveillance data collected at national or subnational levels; data is collected through surveillance of drug resistance by routinely conducting drug susceptibility testing or periodic drug resistance surveys of a nationally representative sample of patients that is repeated every 5 years if the coverage of drug susceptibility testing is not sufficient. Population-representative surveys and surveillance collected between 2000

 to 2018 were used to compare the OR of MDR/RR-TB among children (<15 years) and adults (≥15 years) with TB. Likelihood ratio test was used to assess for an interaction between age group and year at various levels of confidence. ORs less than 1 meant MDR/RR-TB was positively associated with age of at least 15 years; ORs greater than 1 meant MDR/RR-TB was positively associated with age less than 15 years.

Continue Reading

Results suggest that in most settings, the odds of drug resistance are the same for children and adults with TB. Of the 212 countries/territories that reported TB data to WHO, 55 countries had good quality, age-disaggregated data for MDR/RR-TB. Of these 55 countries, 16 countries recorded pediatric MDR/RR-TB cases in both 2000-2011 and 2012-2018; 39 had data reported for one period and not the other, and 19 countries relied on periodic surveys.

Of the 55 included countries, there was strong evidence of ORs less than 1 in Germany, Kazakhstan, Lithuania, Peru, Tajikistan, and Uzbekistan and strong evidence of ORs greater than 1 in United Kingdom and Poland. Weak evidence of ORs greater than 1 were found in Finland and Luxembourg. Data from the 16 countries that recorded data in both time periods suggest strong evidence for decreases in the OR in children when compared to adults in Germany (1.64 [95% CI, 1.12-2.39] in 2000-2011 to 0.26 [95% CI, 0.07-1.07]), Kazakhstan (1.03 [95% CI, 0.71-1.5] to 0.38 [95% CI, 0.31-0.45]), and United States (2.34 [95% CI, 1.45-3.80] to 0.63 [95% CI, 0.28-1.42]), but weak evidence for decrease in Belarus, Namibia, and Uzbekistan.

Lack of statistical significance may not be an indication of a similar force of infection in children and adults, but may reflect limitations and lack of available data. The TB diagnostic algorithm changed over time, resulting in variations in case detection.

Overall, the study authors concluded that “[t]here are important gaps in detection, recording and reporting of drug resistance among pediatric TB cases, limiting our understanding of transmission risks and measures needed to combat the global TB epidemic.”

Reference

McQuaid CF, Cohen T, Dean AS, et al. Ongoing challenges to understanding multidrug and rifampicin-resistant tuberculosis in children vs adults, Published online September 17, 2020. Eur Respir J. doi:10.1183/13993003.02504-2020

Topics:

Respiratory Tuberculosis


Comments

Post a Comment

Popular posts from this blog

Manual on meat inspection for developing countries

-
Image
sinusitis treatment :: Article Creator My 'sinus Infection' Turned Out To Be A One In A Million Nasal Cancer At Just 28 - And Doctors Had To Cut My Eye Out To Save Me By Emily Joshu Health Reporter For Dailymail.Com Published: 06:33 EDT, 20 April 2024Updated: 06:35 EDT, 20 April 2024 A 28 year-old California woman has described the shock of being diagnosed with a deadly sinus cancer that affects fewer than one in a million people - and led to the removal of her right eye. The 'golf ball-sized tumor', which had spread throughout her face, was first mistaken for a sinus infection by the woman's doctors.  Annika, who posts about her condition on TikTok, woke up one morning in 2023 and noticed that the inner corner of her right eye was sore.  While she at first thought nothing of it, by the time the evening rolled around, 'my face started to really, really hurt on the right side,' she said in a video.  The next day, her
Read more

Rash behind ear: Causes, other symptoms, and treatment - Medical News Today

-
Image
A rash behind the ear may occur due to a variety of different medical conditions. Certain viral infections and autoimmune diseases may cause a rash behind the ear in both children and adults. While some causes, such as contact dermatitis, are not concerning, other causes, including rubella, may be more serious. In this article, we look at some of the causes of a rash behind the ear, as well as the other symptoms that they may produce and how to treat them. Contact dermatitis is an allergic reaction to a particular substance. If an allergy-inducing substance comes into contact with the skin behind the ear, a rash can form. Allergens that may cause contact dermatitis behind the ears include: shampoos soaps other hair care products For example, hair dye products contain an ingredient called paraphenylenediamine (PPD), which is a common contact allergen. Symptoms Contact dermatitis causes itchiness, dryness, and flaking of the skin that came into contact with the allergen. Diagnosis A doc
Read more

Having This One Particular Blood Type Can Help Protect You From Severe Malaria - ScienceAlert

-
Image
Nearly  half the world's population is at risk of malaria, one of the most deadly diseases known to humankind. Each year it claims  over 400,000 lives, most of whom are children younger than age five. While it's possible to vaccinate against malaria, virtually all of these cases are in the African region, where protection is often nothing more than a roll of the dice. Now, a recent  analysis  of 23 papers suggests those with blood type O have the genetic odds stacked in their favour. In sub-Saharan Africa, where severe malaria - caused by the  Plasmodium falciparum  parasite  - is endemic, there are far more individuals with blood type O than anywhere in Europe or the US. In Nigeria alone, where 97 percent of the country is at risk of malaria, more than half the population belongs to this blood group. In Ethiopia and many others, the numbers are similar. Rather than a coincidence, co-author and epidemiologist Abraham Degarege Mengist from Robert Stempel College of Publi
Read more